ACTU Financials

Actuate Therapeutics Inc - Financial statements & key metrics

Stock Price

$5.56

Market Cap

$136.67M

EPS

$-3.11

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

Gross Profit

Operating Income

Net Income

$-27.29M

EPS (Diluted)

$-3.26

Balance Sheet Highlights

Total Assets

$9.32M

Total Liabilities

$9.21M

Shareholders Equity

Cash & Equivalents

$8.64M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-21.84M

CapEx

Free Cash Flow

Profitability Metrics

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ACTU revenue?

View ACTU's income statement for detailed revenue data.

Is ACTU profitable?

ACTU reported a loss of $27.29M in the most recent quarter.

What is ACTU market cap?

ACTU has a market capitalization of $136.67M, making it a small-cap stock.

Does ACTU have debt?

View ACTU's balance sheet for debt information.

What is ACTU cash flow?

Cash flow data is available in the full financial statements.